Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trialAxel Bauer, Uwe Dorwarth, Benedikt A. Aulinger et al.|The Lancet Respiratory Medicine|2021Cited by 104
Clinical Potential of C-Reactive Protein and Procalcitonin Serum Concentrations To Guide Differential Diagnosis and Clinical Management of Pneumococcal and <i>Legionella</i> PneumoniaRosa Bellmann‐Weiler, Günter Weiß, Mathias Ausserwinkler et al.|Journal of Clinical Microbiology|2010Cited by 26
Klinisches Potenzial von C-reaktivem Protein und Procalcitonin Serumkonzentrationen für die Differenzialdiagnose und das klinische Management von Pneumokokken- und LegionellenpneumonienRosa Bellmann‐Weiler, Mathias Ausserwinkler, Katharina Schröcksnadel et al.|Pneumologie|2012Cited by 0